Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10004169HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10006529HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013404HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013405HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013406HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013407HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013408HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013409HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013410HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013411HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB06702
Drug NameFesoterodine
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs11752352; 12076307
CitationsChen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Nilvebrant L: Tolterodine and its active 5-hydroxymethyl metabolite: pure muscarinic receptor antagonists. Pharmacol Toxicol. 2002 May;90(5):260-7.
GroupsApproved
Direct ClassificationDiphenylmethanes
SMILESCC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
Pathways
PharmGKBPA165958376
ChEMBLCHEMBL1201764